Signia Therapeutics announces it has been selected to present its strategy based on clinical gene expression infection signatures to the upcoming 2nd edition of i4iD “Immunotherapies for Infectious Diseases – host-directed therapies”. This conference is organized jointly by MabDesign, a French non-profit membership organization in the immunotherapy field, and BIOASTER, a technology institute that leads research … Continue reading Signia Therapeutics to present at the 2nd i4iD – Immunotherapies for infectious Diseases – conference